New Alzheimer’s Drug Receives FDA Approval
Source: NBC News The Food and Drug Administration of approved an Alzheimer’s drug shown in clinical trials to slow cognitive decline in patients in the early stages of the illness. The drug, lecanemab, which will be sold under the name Leqembi, is a monoclonal antibody infusion given every two weeks. The FDA approved Leqembi for […]